Duopharma Biotech bekal insulin RM375.17j

Kuala Lumpur: Duopharma Biotech Bhd dan kerajaan memeterai perjanjian mendapatkan ubat insulin melalui rundingan terus dengan harga RM375.17 juta, menurutnya dalam makluman kepada Bursa Malaysia.

Author(s): -
Copyright: -
Published on: 4 October 2022
Publication: Harian Metro
Items linked to this story
HM - Tue, 10 2022 HM 025 a
Contact us for more information on License Usage.
Additional fees
Historical Fee
RM37.00
(Includes 8% SST) RM112.60
Keywords
insulin
Bursa Malaysia
bernama
xnstp
biocon
DMktg
Similar stories
More similar items